MedTrace Logo

Assessment of Body Composition Via Dual-energy X-ray Absorptiometry Bone Densitometry

NCT02609191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-11-19

No results posted yet for this study

Summary

The main objective of this study is to validate the measurement characteristics of a new bone densitometer, the Stratos DR:

* Via cross calibration to the results of body composition (BC) measurement results to those of a reference device (the "Discover A" by Hologic) in terms of body fat percentage, lean mass percentage of total body mass and for different subregions (left and right arms, left and right sides, lumbar and thoracic spine, pelvis, left and right legs, head, android area, gynecoid area, visceral region).
* And by the evaluation of the reproducibility of the BC measurement results in terms of fat mass and lean mass.

Conditions

  • Osteodensitometry

Interventions

DEVICE

Whole body exam using the "Discovery A"

Whole body exam using the "Discovery A" machine made by Hologic.

DEVICE

First whole body exam using the "Stratos DR"

First whole body exam using the "Stratos DR" machine made by the DMS group.

DEVICE

Second whole body exam using the "Stratos DR"

Second whole body exam using the "Stratos DR" machine made by the DMS group. This second exam is required for reproducibility purposes.

Sponsors & Collaborators

  • DMS Apelem

    collaborator INDUSTRY

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Vincent Boudousq, MD · Centre Hospitalier Universitaire de Nîmes

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-06-01
Completion
2017-06-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02609191 on ClinicalTrials.gov